VitaminLab in its Series A investment round led by Nimbus Synergies and DSM Venturing






Emerging and High Growth Companies

Date Closed

May 2023



Lead Office



On May 8, 2023 , VitaminLab announced the closing of its Series A investment round co-led by Nimbus Synergies and DSM Venturing. VitaminLab plans to utilize the funding to expand their facilities, automation lines and their market activities across North America. The company has been thriving through implementing a direct-to-consumer ecommerce approach and integrations with health testing companies.

VitaminLab, located in Victoria, British Columbia, tests and formulates supplements for individuals, patients and practitioners.

Nimbus Synergies focuses on early-stage financings in innovative and complementary health technology companies in Canada.

DSM Venturing is the corporate venture arm of Royal DSM, which is a global and science focused company in the areas of nutrition, health and sustainable living.

Osler, Hoskin & Harcourt LLP advised VitaminLab with a team consisting of Mark Longo, Manveer Bisla and Ian Nelson (Emerging and High Growth Companies).